Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Manzano

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2011
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)E Aranda, J L Manzano, F Rivera, et al.
Scandinavian Journal of Gastroenterology|March 4, 2005
Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell linesN Aguilera-Montilla, M Pérez-Blas, A P Valeri, et al.
Revista Clinica Espanola|October 7, 2021
Morbidity and mortality in elderly patients with heart failure managed with a comprehensive care model vs. usual care: The UMIPIC programÁ González-Franco, J M Cerqueiro González, J C Arévalo-Lorido, et al.
British Journal of Cancer|July 15, 2010
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapyE Martinez-Balibrea, A Abad, A Martínez-Cardús, et al.
Revista Clinica Espanola|March 23, 2015
Gender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA RegistryA Conde-Martel, M E Arkuch, F Formiga, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2011
Recommendations and expert opinion on the treatment of locally advanced rectal cancer in SpainC Grávalos, P García-Alfonso, R Afonso, et al.
Revista Clinica Espanola|March 13, 2022
Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC programJ M Cerqueiro-González, Á González-Franco, S Carrascosa-García, et al.
Revista Clinica Espanola|November 3, 2024
Benefits of a comprehensive care model in patients with heart failure and chronic obstructive pulmonary disease: UMIPIC ProgramM Méndez Bailón, Á González-Franco, J M Cerqueiro, et al.
Revista Clinica Espanola|February 15, 2015
Spironolactone in patients with heart failure and preserved ejection fractionC Sánchez-Sánchez, H F Mendoza-Ruiz de Zuazu, F Formiga, et al.
Gastroenterology|August 14, 2016
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional CancerAnna Martínez-Cardús, Sebastian Moran, Eva Musulen, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2011
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)E Aranda, J L Manzano, F Rivera, et al.
Scandinavian Journal of Gastroenterology|March 4, 2005
Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell linesN Aguilera-Montilla, M Pérez-Blas, A P Valeri, et al.
Revista Clinica Espanola|October 7, 2021
Morbidity and mortality in elderly patients with heart failure managed with a comprehensive care model vs. usual care: The UMIPIC programÁ González-Franco, J M Cerqueiro González, J C Arévalo-Lorido, et al.
British Journal of Cancer|July 15, 2010
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapyE Martinez-Balibrea, A Abad, A Martínez-Cardús, et al.
Revista Clinica Espanola|March 23, 2015
Gender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA RegistryA Conde-Martel, M E Arkuch, F Formiga, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2011
Recommendations and expert opinion on the treatment of locally advanced rectal cancer in SpainC Grávalos, P García-Alfonso, R Afonso, et al.
Revista Clinica Espanola|March 13, 2022
Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC programJ M Cerqueiro-González, Á González-Franco, S Carrascosa-García, et al.
Revista Clinica Espanola|November 3, 2024
Benefits of a comprehensive care model in patients with heart failure and chronic obstructive pulmonary disease: UMIPIC ProgramM Méndez Bailón, Á González-Franco, J M Cerqueiro, et al.
Revista Clinica Espanola|February 15, 2015
Spironolactone in patients with heart failure and preserved ejection fractionC Sánchez-Sánchez, H F Mendoza-Ruiz de Zuazu, F Formiga, et al.
Gastroenterology|August 14, 2016
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional CancerAnna Martínez-Cardús, Sebastian Moran, Eva Musulen, et al.
Pageof 18